Altria/NJOY Deal Rationale

Altria recently agreed to acquire NJOY for up to $3.25B, with PWP and Moelis doing the heavy lifting on advising Altria and NJOY, respectively. It seems like a way overpriced move for Altria to be paying such an amount for a company with only 3% of the US vape market share, even if NJOY's trump card is that they have FDA approval for their products which the No. 1 and 2 market leaders in the US are struggling with. Considering that Altria has an IP-sharing agreement with Juul, why don't they just develop an in-house product rather than spend such a premium acquiring NJOY, especially after the whole Juul fiasco? Would love to hear some more discussion about this.

19 Comments
 
Most Helpful

In the C&R space but not an alcohol & tobacco banker so could be wrong, but it seems like the major roadblock in the vaping space is FDA approval - the feds have been super slow with approving vaping products, and NJOY has the only pod-based vape that's FDA authorized, so Altria likely saw the acquisition as more of an IP acquisition that allows them to skip the roadblocks they'd face with developing their own technology. The 3% market share isn't probably too concerning for Altria, given their brand image and marketing power as one of the tobacco giants. 

Also anyone know which specific bankers were working on the deal?

 

Hot take but the Juul investment wasn't as bad as it seems. Most importantly, with the Juul investment Altria ensured the next generation's market for nicotine. In the US, Juul's made e-cigarettes as iconic and commonplace among the younger generation as Marlboro Reds were to older smokers. The way I see it, Altria paid $12B to secure an entire generation of future smokers.

 

Autem nulla id et deserunt deserunt amet et. Veniam quos ut id et. Molestiae et omnis a debitis cupiditate. Suscipit a excepturi sed aspernatur. Consequatur animi neque provident provident cumque excepturi doloremque. Consequatur deleniti numquam et sed.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (48) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (83) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”